Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörg Kraus

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical Biochemistry|October 21, 2021
Laboratory biomarkers of Multiple Sclerosis (MS)Borros Arneth, Jörg Kraus
Wiener Medizinische Wochenschrift (1946)|March 7, 2022
Experimental laboratory biomarkers in multiple sclerosisBorros Arneth, Jörg Kraus
Drug Discovery Today|July 19, 2006
The impact of interferon-beta treatment on the blood-brain barrierJörg Kraus, Patrick Oschmann
Medicina (Kaunas, Lithuania)|November 11, 2022
The Use of Kappa Free Light Chains to Diagnose Multiple SclerosisBorros Arneth, Jörg Kraus
Drug Discovery Today|September 9, 2008
Modern multiple sclerosis treatment - what is approved, what is on the horizonGeorg Pilz, Peter Wipfler, Gunther Ladurner, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapyMonika Killer, Eugen Trinka, Jörg Kraus, et al.
The Neurohospitalist|April 7, 2018
Geriatric Basics for the NeurohospitalistJosef G Heckmann, Jörg Kraus, Christoph J G Lang
Drug Discovery Today|May 28, 2013
Treatment strategies for vasculitis that affects the nervous systemErasmia Broussalis, Eugen Trinka, Jörg Kraus, et al.
Clinical Neurology and Neurosurgery|February 15, 2005
Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcomeErwin Stolz, Anousha Rahimi, Tibo Gerriets, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Thrombocyte activation increases with the degree of carotid artery stenosisErwin Stolz, Patrick Oschmann, Bernd Pötzsch, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical Biochemistry|October 21, 2021
Laboratory biomarkers of Multiple Sclerosis (MS)Borros Arneth, Jörg Kraus
Wiener Medizinische Wochenschrift (1946)|March 7, 2022
Experimental laboratory biomarkers in multiple sclerosisBorros Arneth, Jörg Kraus
Drug Discovery Today|July 19, 2006
The impact of interferon-beta treatment on the blood-brain barrierJörg Kraus, Patrick Oschmann
Medicina (Kaunas, Lithuania)|November 11, 2022
The Use of Kappa Free Light Chains to Diagnose Multiple SclerosisBorros Arneth, Jörg Kraus
Drug Discovery Today|September 9, 2008
Modern multiple sclerosis treatment - what is approved, what is on the horizonGeorg Pilz, Peter Wipfler, Gunther Ladurner, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapyMonika Killer, Eugen Trinka, Jörg Kraus, et al.
The Neurohospitalist|April 7, 2018
Geriatric Basics for the NeurohospitalistJosef G Heckmann, Jörg Kraus, Christoph J G Lang
Drug Discovery Today|May 28, 2013
Treatment strategies for vasculitis that affects the nervous systemErasmia Broussalis, Eugen Trinka, Jörg Kraus, et al.
Clinical Neurology and Neurosurgery|February 15, 2005
Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcomeErwin Stolz, Anousha Rahimi, Tibo Gerriets, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Thrombocyte activation increases with the degree of carotid artery stenosisErwin Stolz, Patrick Oschmann, Bernd Pötzsch, et al.
Pageof 6